Poor countries to get new AIDS pill

July 6, 2006

A new 3-in-1 AIDS pill made in India and approved by U.S. drug regulators is expected to treat patients in poor countries.

The pill made by an Indian generic drug company is the first such antiretroviral treatment approved by the Food and Drug for patients in countries helped by the President's Emergency Plan for AIDS Relief, reports The New York Times.

Dr. Mark R. Dybul, the White House global AIDS coordinator, said the new pill should greatly improve treatment for patients in poor countries.

Under a White House plan, the United States has become the largest provider of antiretroviral drugs in the world. The plan helps treat some 561,000 patients in Africa, Asia and the Caribbean, the Times reported.

The new pill, made by Aurobindo Pharma of Hyderabad, India, combines three common first-line drugs, AZT, 3TC and NVP, which are sold in the United States as Retrovir, Epivir and Viramune, the report said.

Copyright 2006 by United Press International

Explore further: Once-daily pill effective as multiple dosings for oral yeast infection in HIV/AIDS patients

Related Stories

Brain tumor cells decimated by mitochondrial 'smart bomb'

March 24, 2015

An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.

New insights into placebo effect

August 31, 2012

(Phys.org)—Mathematical models developed by scientists at the University of Bristol are providing new insights into why the placebo effect exists and when it should occur. Their research is published today in the journal ...

NFC aid for the visually and hearing impaired

February 9, 2012

As the proportion of senior citizens grows, their special needs are gaining momentum. Human eyesight, for example, weakens with age. VTT Technical Research Centre of Finland has been developing new NFC-based applications ...

30 years after first AIDS cases, hope for a cure

June 3, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

Revisiting ADHD and Ritalin

May 17, 2011

Fifteen years ago, Dr. Lawrence H. Diller, a pediatrician from Walnut Creek, Calif., ignited a national debate over the steep rise in children being diagnosed with attention-deficit hyperactivity disorder and treated with ...

Recommended for you

How much for that Nobel prize in the window?

October 3, 2015

No need to make peace in the Middle East, resolve one of science's great mysteries or pen a masterpiece: the easiest way to get yourself a Nobel prize may be to buy one.

Trade in invasive plants is blossoming

October 3, 2015

Every day, hundreds of different plant species—many of them listed as invasive—are traded online worldwide on auction platforms. This exacerbates the problem of uncontrollable biological invasions.

Drone market to hit $10 billion by 2024: experts

October 3, 2015

The market for military drones is expected to almost double by 2024 to beyond $10 billion (8.9 billion euros), according to a report published Friday by specialist defence publication IHS Jane's Intelligence Review.

Fusion reactors 'economically viable' say experts

October 2, 2015

Fusion reactors could become an economically viable means of generating electricity within a few decades, and policy makers should start planning to build them as a replacement for conventional nuclear power stations, according ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.